The tumor cell-intrinsic cGAS-STING pathway is associated with the high density of CD8+ T cells after chemotherapy in esophageal squamous cell carcinoma
- PMID: 38324215
- DOI: 10.1007/s10388-024-01044-0
The tumor cell-intrinsic cGAS-STING pathway is associated with the high density of CD8+ T cells after chemotherapy in esophageal squamous cell carcinoma
Abstract
Background: Chemotherapy has the potential to induce CD8+ T-cell infiltration in the tumor microenvironment (TME) and activate the anti-tumor immune response in several cancers including esophageal squamous cell carcinoma (ESCC). The tumor cell-intrinsic cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway has been known as a critical component for regulating immune cell activation in the TME. However, its effect on the infiltration of immune cells induced by chemotherapy in the ESCC TME has not been investigated.
Methods: We examined the effect of the tumor-cell intrinsic cGAS-STING pathway on the infiltration of CD8+ T cells induced by chemotherapy in ESCC using ESCC cell lines and surgically resected ESCC specimens from patients who received neoadjuvant chemotherapy (NAC).
Results: We found that chemotherapeutic agents, including 5-fluorouracil (5-FU) and cisplatin (CDDP), activated the cGAS-STING pathway, consequently inducing the expression of type I interferon and T-cell-attracting chemokines in ESCC cells. Moreover, the tumor cell-intrinsic expression of cGAS-STING was significantly and positively associated with the density of CD8+ T cells in ESCC after NAC. However, the tumor cell-intrinsic expression of cGAS-STING did not significantly impact clinical outcomes in patients with ESCC after NAC.
Conclusion: Our findings suggest that the tumor cell-intrinsic cGAS-STING pathway might contribute to chemotherapy-induced immune cell activation in the ESCC TME.
Keywords: 5-FU; CDDP; Chemotherapy; ESCC; cGAS–STING.
© 2024. The Author(s) under exclusive licence to The Japan Esophageal Society.
Similar articles
-
Radiation-Induced Remodeling of the Tumor Microenvironment Through Tumor Cell-Intrinsic Expression of cGAS-STING in Esophageal Squamous Cell Carcinoma.Int J Radiat Oncol Biol Phys. 2023 Mar 15;115(4):957-971. doi: 10.1016/j.ijrobp.2022.10.028. Epub 2022 Nov 8. Int J Radiat Oncol Biol Phys. 2023. PMID: 36368436
-
[Remodeling of the Tumor Microenvironment by Radiotherapy through the cGAS-STING Pathway in Esophageal Squamous Cell Carcinoma].Gan To Kagaku Ryoho. 2023 Oct;50(10):1099-1101. Gan To Kagaku Ryoho. 2023. PMID: 38035843 Japanese.
-
High levels of tumor cell-intrinsic STING signaling are associated with increased infiltration of CD8+ T cells in dMMR/MSI-H gastric cancer.Sci Rep. 2024 Sep 6;14(1):20859. doi: 10.1038/s41598-024-71974-3. Sci Rep. 2024. PMID: 39242811 Free PMC article.
-
DNA sensing in cancer: Pro-tumour and anti-tumour functions of cGAS-STING signalling.Essays Biochem. 2023 Sep 28;67(6):905-918. doi: 10.1042/EBC20220241. Essays Biochem. 2023. PMID: 37534795 Free PMC article. Review.
-
The pleiotropic roles of cGAS-STING signaling in the tumor microenvironment.J Mol Cell Biol. 2022 Aug 5;14(4):mjac019. doi: 10.1093/jmcb/mjac019. J Mol Cell Biol. 2022. PMID: 35325182 Free PMC article. Review.
Cited by
-
Activation of the tumor cell-intrinsic STING pathway induced by Fusobacterium nucleatum is associated with poor prognosis in esophageal cancer patients.Esophagus. 2025 Apr;22(2):239-249. doi: 10.1007/s10388-025-01112-z. Epub 2025 Feb 14. Esophagus. 2025. PMID: 39951185
-
cGAS/STING pathway and gastrointestinal cancer: Mechanisms and diagnostic and therapeutic targets (Review).Oncol Rep. 2025 Jan;53(1):15. doi: 10.3892/or.2024.8848. Epub 2024 Nov 29. Oncol Rep. 2025. PMID: 39611480 Free PMC article. Review.
-
Downregulation of cGAS/STING expression in tumor cells by cancer-associated fibroblasts in colorectal cancer.Sci Rep. 2025 Jun 2;15(1):19234. doi: 10.1038/s41598-025-03924-6. Sci Rep. 2025. PMID: 40451897 Free PMC article.
References
-
- Kato K, Ito Y, Daiko H, et al. A randomized controlled phase III trial comparing two chemotherapy regimen and chemoradiotherapy regimen as neoadjuvant treatment for locally advanced esophageal cancer, JCOG1109 NExT study. J Clin Oncol. 2022;40:238. - DOI
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical
Research Materials